PMID- 12955176 OWN - NLM STAT- MEDLINE DCOM- 20040413 LR - 20210410 IS - 0342-4642 (Print) IS - 0342-4642 (Linking) VI - 29 IP - 12 DP - 2003 Dec TI - Human leukocyte antigen-DR expression in peripheral blood mononuclear cells from healthy donors influenced by the sera of injured patients prone to severe sepsis. PG - 2285-2290 LID - 10.1007/s00134-003-1992-8 [doi] AB - OBJECTIVE: To study the influence of sera from severely injured patients on the human leukocyte antigen (HLA)-DR expression of normal peripheral blood mononuclear cells (PBMC). DESIGN: In vitro study. SETTING: University hospital. PATIENTS AND PARTICIPANTS: Sera from 34 patients were obtained within 8 h after trauma. Seventeen of these patients developed posttraumatic sepsis (sepsis group) and 17 recovered without infectious complications. Sera from ten healthy individuals served as controls. Phytohemagglutinin (PHA)-activated PBMC from 44 healthy donors were used to study the effects of a patient's serum. MEASUREMENTS AND RESULTS: Medium containing 5% of serum from the sepsis group significantly ( p<0.05) reduced the HLA-DR expression (channels, mean +/- standard error of the mean) on monocytes (patients 883+/-22, controls 962+/-15), B (patients 922+/-14, controls 972+/-7) and T cells (patients 932+/-13, controls 968+/-5) of PHA-activated PBMC. Significantly increased accumulation of TNFalpha on (1.8+/-0.4% of PBMC) and within T cells (0.98+/-0.26% of PBMC) was observed by flow cytometry after incubation with medium containing sera of the sepsis group compared with controls (on 0.5+/-0.1%, within 0.27+/-0.05% of PBMC). A significant negative correlation between relative cell counts of intracellular TNFalpha-positive T cells with HLA-DR expression was observed for monocytes ( r= -0.61), B cells ( r= -0.57) and proliferation ( r= -0.68) as estimated by (3)H-thymidine uptake [patients 139971+/-12844 counts per minute (cpm), controls 198973+/-19347 cpm, p<0.05] in the presence of sera from the sepsis group. CONCLUSIONS: Reduced cellular immunity and, therefore, immunodeficiency after trauma appears to be caused by soluble factors influencing T cell function in particular. FAU - Mueller, Anke AU - Mueller A AD - Institute of Immunology, University of Essen, Virchowstrasse 171, 45122 , Essen, Germany. FAU - Kreuzfelder, Ernst AU - Kreuzfelder E AD - Institute of Immunology, University of Essen, Virchowstrasse 171, 45122 , Essen, Germany. FAU - Nyadu, Baerbel AU - Nyadu B AD - Institute of Immunology, University of Essen, Virchowstrasse 171, 45122 , Essen, Germany. FAU - Lindemann, Monika AU - Lindemann M AD - Institute of Immunology, University of Essen, Virchowstrasse 171, 45122 , Essen, Germany. FAU - Rebmannn, Vera AU - Rebmannn V AD - Institute of Immunology, University of Essen, Virchowstrasse 171, 45122 , Essen, Germany. FAU - Majetschak, Matthias AU - Majetschak M AD - Department of Trauma Surgery, University Hospital Mannheim, Ruprecht-Karls University, Theodor-Kutzer-Ufer 1-3, 68167 , Mannheim, Germany. FAU - Obertacke, Udo AU - Obertacke U AD - Department of Trauma Surgery, University Hospital Mannheim, Ruprecht-Karls University, Theodor-Kutzer-Ufer 1-3, 68167 , Mannheim, Germany. FAU - Schade, Ulrich F AU - Schade UF AD - Department of Trauma Surgery, University of Essen, Hufelandstr. 55, 45122 , Essen, Germany. FAU - Nast-Kolb, Dieter AU - Nast-Kolb D AD - Department of Trauma Surgery, University of Essen, Hufelandstr. 55, 45122 , Essen, Germany. FAU - Grosse-Wilde, Hans AU - Grosse-Wilde H AD - Institute of Immunology, University of Essen, Virchowstrasse 171, 45122 , Essen, Germany. immunologie@uni-essen.de. LA - eng PT - Journal Article DEP - 20030904 PL - United States TA - Intensive Care Med JT - Intensive care medicine JID - 7704851 RN - 0 (HLA-DR Antigens) SB - IM MH - Adult MH - Aged MH - Case-Control Studies MH - Female MH - Flow Cytometry MH - HLA-DR Antigens/*blood/immunology MH - Humans MH - Injury Severity Score MH - Leukocytes, Mononuclear/*immunology MH - Male MH - Middle Aged MH - Sepsis/*blood/immunology MH - Wounds and Injuries/*blood/classification EDAT- 2003/09/05 05:00 MHDA- 2004/04/14 05:00 CRDT- 2003/09/05 05:00 PHST- 2002/08/27 00:00 [received] PHST- 2003/08/01 00:00 [accepted] PHST- 2003/09/05 05:00 [pubmed] PHST- 2004/04/14 05:00 [medline] PHST- 2003/09/05 05:00 [entrez] AID - 10.1007/s00134-003-1992-8 [pii] AID - 10.1007/s00134-003-1992-8 [doi] PST - ppublish SO - Intensive Care Med. 2003 Dec;29(12):2285-2290. doi: 10.1007/s00134-003-1992-8. Epub 2003 Sep 4.